Michael E. Weinblatt, MD
Disclosures: Grants/Research Support Recipient-Crescendo Bioscience, Bristol Myers Squibb, Sanofi-Regeneron, Lilly, Amgen-n/a|Stock Shareholder (excluding mutual funds)-Canfite, Inmedix, Lycera, Vorso, Scipher|Consultant-AbbVie, Amgen, Arena, BMS, Canfite, Corrona, Crescendo, GSK, Gilead, Horizon, Lilly, Lycera, Novartis, Pfizer, Roche, Samsung, Scipher, Set Point
No Bio Available.